Reflux Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Thane, Maharashtra, India, established in 2020.

2020 Thane, Maharashtra, India Active

Last Updated: December 21, 2025

About Reflux Pharmaceuticals Private Limited

Reflux Pharmaceuticals Private Limited, a active private limited company, was established on 03 February 2020 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999MH2020PTC337046. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹7.68 M.

It upholds a compliant status. Its leadership includes Jaid Ismail Kojar (Nominee Director), Amit Kumar Ghosh (Director), Sandeep Khandu Tekle (Director). It holds ₹8.50 Cr open charges and ₹5.18 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Gala No. 83, 3Rd Floor, C-39/A, Gami Industrial Park, Ttc Industrial Area, Midc Pavane, Thane, Maharashtra, 400705.

Company Details

CIN/LLPIN
U74999MH2020PTC337046
Registration Number
337046
Incorporation Date
03 February 2020
Authorized Capital
₹5.00 Cr
Paid-Up Capital
₹7.68 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 5.00 Cr as on 21-12-2025
Paid Up Capital ₹ 7.68 M as on 21-12-2025
Company Age 6 Year, 8 Days
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 8.50 Cr as on 21-12-2025
Satisfied Charges ₹ 5.18 Cr as on 21-12-2025
Revenue Growth **** 386.06% (FY 2022)
Profit Growth **** -5.71% (FY 2022)
Ebitda **** 16.11% (FY 2022)
Net Worth 91.01% (FY 2022)
Total Assets **** 63.69% (FY 2022)

Comprehensive Company Insights

Explore comprehensive insights into Reflux Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Reflux Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Jaid Ismail Kojar	Nominee Director	29 Jul 2024	Current
Amit Kumar Ghosh	Director	03 Feb 2020	Current
Sandeep Khandu Tekle	Director	03 Feb 2020	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Reflux Pharmaceuticals.

Reflux Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 386.06% increase. The company also saw a slight decrease in profitability, with a 5.71% decrease in profit. The company's net worth Soared by an impressive increase of 91.01%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

386.06%

*******

Revenue from Operations

*******

384.47%

*******

Total Assets

*******

63.69%

*******

Profit or Loss

*******

-5.71%

*******

Net Worth

*******

91.01%

*******

EBITDA

*******

16.11%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Reflux Pharmaceuticals?

Unlock access to Reflux Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹85,000,000.00

Satisfied Charges

₹51,800,000.00

Charges Breakdown by Lending Institutions

Others : 8.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
09 Mar 2023	Others	₹8.50 Cr	Open
17 Mar 2022	Others	₹5.18 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Reflux Pharmaceuticals?

Unlock and access historical data on people associated with Reflux Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Reflux Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reflux Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Reflux Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

The activity Reflux Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
30 Sep 2024
Director Appointment

Jaid Ismail Kojar was appointed as a Nominee Director was appointed as a Nominee Director on 29 Jul 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
29 Jul 2024
Balance Sheet

Reflux Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
31 Mar 2024
Charges

The activity A charge registered on 17 Mar 2022 via Charge ID 100587794 with Others was fully satisfied on 10 Aug 2023. was completed.
10 Aug 2023
Charges

Progress on A charge with Others of Rs. 8.50 Cr registered on 09 Mar 2023 with Charge ID 100701436 was modified on 16 Jun 2023. was documented.
16 Jun 2023
Charges

A charge with Others amounted to Rs. 8.50 Cr with Charge ID 100701436 was registered on 09 Mar 2023. was recorded as a recent event.
09 Mar 2023

Explore recent activity and updates - View Recent Activity